Class information for:
Level 1: MURINE PLASMACYTOMA//MICROENCAPSULATED CELLS//RECOMBINANT INTERLEUKIN 1 ALPHA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
18973 461 37.5 79%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
283 18382 EXPERIMENTAL HEMATOLOGY//G CSF//PLERIXAFOR

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 MURINE PLASMACYTOMA Author keyword 4 75% 1% 3
2 MICROENCAPSULATED CELLS Author keyword 2 67% 0% 2
3 RECOMBINANT INTERLEUKIN 1 ALPHA Author keyword 2 67% 0% 2
4 Y 25510 Author keyword 2 67% 0% 2
5 MYELODEPRESSION Author keyword 1 50% 0% 2
6 SONICATED TUMOR SUPERNATANT Author keyword 1 100% 0% 2
7 ACTIVE SPECIFIC IMMUNIZATION Author keyword 1 40% 0% 2
8 TUMOR HOST INTERACTIONS Author keyword 1 21% 1% 3
9 ACUTE RADIATION REACTION Author keyword 1 50% 0% 1
10 ANTI P19 Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 MURINE PLASMACYTOMA 4 75% 1% 3 Search MURINE+PLASMACYTOMA Search MURINE+PLASMACYTOMA
2 MICROENCAPSULATED CELLS 2 67% 0% 2 Search MICROENCAPSULATED+CELLS Search MICROENCAPSULATED+CELLS
3 RECOMBINANT INTERLEUKIN 1 ALPHA 2 67% 0% 2 Search RECOMBINANT+INTERLEUKIN+1+ALPHA Search RECOMBINANT+INTERLEUKIN+1+ALPHA
4 Y 25510 2 67% 0% 2 Search Y+25510 Search Y+25510
5 MYELODEPRESSION 1 50% 0% 2 Search MYELODEPRESSION Search MYELODEPRESSION
6 SONICATED TUMOR SUPERNATANT 1 100% 0% 2 Search SONICATED+TUMOR+SUPERNATANT Search SONICATED+TUMOR+SUPERNATANT
7 ACTIVE SPECIFIC IMMUNIZATION 1 40% 0% 2 Search ACTIVE+SPECIFIC+IMMUNIZATION Search ACTIVE+SPECIFIC+IMMUNIZATION
8 TUMOR HOST INTERACTIONS 1 21% 1% 3 Search TUMOR+HOST+INTERACTIONS Search TUMOR+HOST+INTERACTIONS
9 ACUTE RADIATION REACTION 1 50% 0% 1 Search ACUTE+RADIATION+REACTION Search ACUTE+RADIATION+REACTION
10 ANTI P19 1 50% 0% 1 Search ANTI+P19 Search ANTI+P19

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RECOMBINANT HUMAN INTERLEUKIN 1 ALPHA 18 46% 6% 29
2 SYNGENEIC TUMORS 11 65% 2% 11
3 LINE NIH OVCAR 3 4 67% 1% 4
4 RECOMBINANT INTERLEUKIN 1 ALPHA 3 37% 2% 7
5 ANTIBACTERIAL RESISTANCE 3 18% 3% 13
6 HISTOINCOMPATIBLE BONE MARROW 2 67% 0% 2
7 HEMOPOIETIN 1 2 25% 1% 6
8 INTERLEUKIN 1 INDUCED NONSPECIFIC RESISTANCE 1 100% 0% 2
9 MELANOMA HEPATIC METASTASIS 1 100% 0% 2
10 SYSTEMIC IL 1 1 100% 0% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Why not treat human cancer with interleukin-1 blockade? 2010 76 108 16%
Interleukin 1 trials in cancer patients: A review of the toxicity, antitumor and hematopoietic effects 1996 35 37 43%
Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? 2008 85 115 25%
Unique versus redundant functional of IL-1 alpha and IL-1 beta in the tumor microenvironment 2013 11 100 24%
Interleukin-1 - a major pleiotropic cyrtokine in tumor-host interactions 2002 103 98 29%
The role IL-1 in tumor-mediated angiogenesis 2014 16 151 13%
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions 2006 176 151 19%
Radio- and chemoprotection of bone marrow cells by opposite cell cycle-acting cytokines 1997 18 50 36%
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment 2006 107 42 21%
INTERLEUKIN-1 IN THE TREATMENT OF CANCER 1995 13 35 40%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 IMMUNE REGULATOSLO UNIV HOSP 1 50% 0.2% 1
2 IMMUNOL10666 N TORREY PINES RD 1 50% 0.2% 1
3 SUNNYBROOK HLTH SCI DERMATOL 1 50% 0.2% 1
4 UNITE 313 1 50% 0.2% 1
5 VF FOCK PHYS 1 50% 0.2% 1
6 CEDARS SINAI MED MED HEMATOL ONCOL 0 33% 0.2% 1
7 PHARM NAT SYNTHET DRUGS 0 33% 0.2% 1
8 PHARM PHYTOCHEM 0 33% 0.2% 1
9 RADIOBIOL PATHOL 0 33% 0.2% 1
10 IMM18 0 25% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000268418 INTERLEUKIN 1 RECEPTOR ANTAGONIST//IL 1 RECEPTOR ANTAGONIST//LYMPHOKINE RESEARCH
2 0.0000160198 AS101//SAFDIE AIDS IMMUNOL//CAIR
3 0.0000107542 G CSF//GM CSF//GRANULOCYTE COLONY STIMULATING FACTOR
4 0.0000100447 FLT1 PEPTIDE//ANTI FLT1 PEPTIDE//RETINYL
5 0.0000080595 PCR GENE REARRANGEMENT//PH1 POSITIVE ALL//MED CLIN MOLEC BIOL
6 0.0000075083 JIXUETENG//SPATHOLOBUS SUBERECTUS DUNN//CHRONIC LOW DOSE IRRADIATION
7 0.0000070143 HIGH DOSE METHYLPREDNISOLONE//GRP MOL ONCOSURG//AMINOSTEROID
8 0.0000066726 IL 1RN//INTERLEUKIN 1 BETA GENE//INTERLEUKIN 1B
9 0.0000065510 MORRIS HEPATOMA 5123//TNF RECEPTORS//ENDOGENOUS TNF ALPHA
10 0.0000060150 RADIAT COUNTERMEASU PROGRAM//ARMED FORCES RADIOBIOL//ACUTE RADIATION SYNDROME